Trials / Completed
CompletedNCT01950546
Nanosilver Fluoride to Prevent Dental Biofilms Growth
Nanosilver Fluoride: a Microbiological and Clinical Trial
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of Pernambuco · Academic / Other
- Sex
- All
- Age
- 5 Years – 6 Years
- Healthy volunteers
- Accepted
Summary
This study aims to evaluate the effectiveness of nanosilver fluoride for controlling the growth of S. mutans present in dental plaque of children.
Detailed description
The product will be apllied on cervical vestibular surfaces of incisors and canines healthy, with a total of 8 teeth, 4 upper and 4 below. Children will be instructed not to ingest any liquid or food within two hours after application. After a period of 7 days will be carried biofilm colect of cervical dental surfaces of incisors and / or canines upper and lower, with the aid of sterile spatulas. This material will be packaged in pre-weighed microfuge tubes containing 1.5 ml of buffered saline solution (0.9% sodium chloride), and transported under refrigeration immediately to the laboratory where analysis will be performed and the S. mutans colonies will be counted. The biofilm collect and posterior laboratorial analysis will be performed weekly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | nanosilver fluoride | The product will be applied in the volunteers in the morning, before the first class, in relative isolation, made with cotton rolls and Vaseline to protect the soft tissue. It will apply 30mg of the product with microbrush, previously standardized in a pilot study on cervical vestibular surfaces of incisors and canines healthy, on a total of 8 teeth, 4 upper and 4 lower. After a period of 7 days,the cervical dental biofilms will be collect, third on the buccal surfaces of incisors and / or canines upper and lower, with the aid of sterile spatulas. |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2014-12-01
- Completion
- 2015-01-01
- First posted
- 2013-09-25
- Last updated
- 2015-06-10
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01950546. Inclusion in this directory is not an endorsement.